25
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Subcellular Distribution of Urokinase and Urokinase Receptor in Human Neutrophils Determined by Immunoelectron Microscopy

, , , , &
Pages 175-182 | Published online: 10 Jul 2009

References

  • Ellis V, Ploug M, Plesner T, Danø K. Gene expression and function of the cellular receptor for uPA (uPAR). In: Glas-Greenwalt P, ed. Fibrinolysis in Disease. Molecular and Hemovascular Aspects of Fibrinolysis. Boca Raton, FL: CRC; 1995:30±42.
  • Plesner T, Behrendt N, Ploug M. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Stem Cells. 1997;15:398±408.
  • Plesner T, Ralfkiñr E, Wittrup M, et al. Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue. Am J Clin Pathol. 1994;102:835±841.
  • Plesner T, Ploug M, Ellis V, et al. The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellula r compartments to the plasma membrane on stimulation of human neutrophils. Blood. 1994;83:808±815.
  • Kjeldsen L, Bainton DF, Sengeløv H, Borregaard N. Structural and functional heterogeneity among peroxidase-negative granules in human neutrophils: identi®cation of a distinct gelatinase-containing granule subset by combined immunocytochemistry and subcellular fractionation. Blood. 1993;82:3183±3191.
  • Kjeldsen L, Sengeløv H, Lollike K, Nielsen MH, Borregaard N. Isolation and characterizatio n of gelatinase granules from human neutrophils. Blood. 1994;83:1640±1649.
  • Rønne E, Behrendt N, Ellis V, Ploug M, Danø K, Høyer-HansenG. Cell-induced potentiation of the plasminogen activatio n system is abolished by a monoclonal antibody that recognizes the NH2- terminal domain of the urokinase receptor. FEBS Lett. 1991;288:233±236.
  • Nielsen LS, Grøndahl-Hansen J, Andreasen PA, Skriver L, Zeuthen J, Danø K. Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its proenzyme using a combination of monoclonal and polyclonal antibodies. J Immunoassay. 1986;7:209±228.
  • Larsson LI. Immunocytochemistry: Theory and Practice. Boca Raton, FL: CRC; 1988.
  • Rice WG, Ganz T, Kinkade JMJ, Selsted ME, Lehrer RI, Parmley RT. Defensin-rich dense granules of human neutrophils. Blood. 1987;70:757±765.
  • Parmley RT, Rice WG, Kinkade JMJ, Gilbert C, Barton JC. Peroxidase-containing microgranules in human neutrophils: physical, morphological, cytochemical, and secretory properties. Blood. 1987;70:1630±1638.
  • Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood. 1997;89:3503±3521.
  • Sakaguchi H, Seki S, Tsubouchi H, Daikuhara Y, Niitani Y, Kobayashi K. Ultrastructural location of human hepatocyte growth factor in human liver. Hepatology. 1994;19:1157±1163.
  • Naldini L, Tamagnone L, Vigna E, et al. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/ scatter factor. EMBO J. 1992;11:4825±4833.
  • Mars WM, Zarnegar R, Michalopoulos GK. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol. 1993;143:949±958.
  • Naldini L, Vigna E, Bardelli A, Follenzi A, Galimi F, Comoglio PM. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J BiolChem. 1995;270:603±611.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.